19 June 2013
Keywords: ph, iii, acurox, trial, enrolled, drugmakers, king
Article | 05 May 2008
US drugmakers King Pharmaceuticals and Acura Pharmaceuticals have announced the completion of patient enrollment for the pivotal Phase
III clinical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 May 2008
18 June 2013
© 2013 thepharmaletter.com